Bahija jallal biography of donald

  • Born in Morocco and university-educated in Paris, Bahija started her work in oncology in Germany, later came to California to work in research at Sugen, spent.
  • Chair of the Board of Viela Bio, a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
  • Bahija Jallal knows biologics, having spent the past 11 years working in and overseeing R&D at AstraZeneca's biologics organization MedImmune.

    • •

    We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gender and race diversity are a business case and how AI is changing protein and biologics engineering.

    I’ve “known” Bahija for over 10 years, after reading her profile in a lärling pharma magazine when I was studying bioengineering in France. At that time, she was head of MedImmune and SVP R&D at AstraZeneca. Now as the CEO of Immunocore, with their pioneering T cell receptor platform, she has helped to bring incredible treatments for cancer patients to market.

    🔗 LINKS MENTIONED

    &#; Bahija on the Breakthrough Labs podcast

    &#; Immatics builds on its PRAME Success (and competes with Immunocore)

    Bahija Jallal: We had one patient. She

  • bahija jallal biography of donald

    • •

    Bahija Jallal: pharma’s Woman of the Year in a landmark 12 months

    AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Woman of the Year for – in what turned out to be a watershed year for women’s rights. She joined HBA CEO Laurie Cooke at a meeting in London recently to reflect on how she made it to the top in pharma R&D – and how more can be done in pharma and biotech to promote gender equality.

    The subject of gender equality and sexual harassment exploded into global consciousness in , largely due to the revelations around film producer Harvey Weinstein, and the subsequent #MeToo movement – an outpouring of testimony from women who have suffered from similar sexual harassment and discrimination.

    This outrage has been harnessed by the #TimesUp campaign, which has re-energised debate in society about how to not only eliminate sexual harassment, but also to bring about equality in the workplace. That’s because de

    •

    Who is Bahija?

    Bahija admits she never had a development strategi for her career, but knew if she did things she really loved she’d succeed. The former President of MedImmune and current CEO of Immunocore, Bahija is one of only a handful of women to lead a company to IPO, but she cites her first biotech job as the best thing to happen to her because it was all about the science. And while she strongly believes to be an effective CEO you need to stay close to the science, she says science by itself fryst vatten not enough, and you need to couple it with both strategy and vision.

    Here she shares more on why failure fryst vatten great, what you must ask yourself before every decision, why diversity is an intricate part of innovation, and the most crucial tool for talking with investors.

    ‍

    01

    Failure is a step on the way to success

    Drug development and science is not for the faint of heart and you have to be resilient. When you are pioneering targeted therapy, you take significant risks going